Related Experiment Videos
Rheosmin, a naturally occurring phenolic compound inhibits LPS-induced iNOS and COX-2 expression in RAW264.7 cells by
Jin Boo Jeong1, Hyung Jin Jeong
1Bioresource Sciences, Andong National University, Andong 760749, Republic of Korea.
Abstract:
Inflammation is part of the host defense mechanism against harmful matters and injury; however, aberrant inflammation is associated to the development of chronic disease such as cancer. Raspberry ketone is a natural phenolic compound. It is used in perfumery, in cosmetics, and as a food additive to impart a fruity odor. In this study, we evaluated whether rheosmin, a phenolic compound isolated from pine needles regulates the expression of iNOS and COX-2 protein in LPS-stimulated RAW264.7 cells. Rheosmin dose-dependently inhibited NO and PGE(2) production and also blocked LPS-induced iNOS and COX-2 expression. Rheosmin potently inhibited the translocation of NF-kappaB p65 into the nucleus by IkappaB degradation following IkappaB-alpha phosphorylation. This result shows that rheosmin inhibits NF-kappaB activation. In conclusion, our results suggest that rheosmin inhibits LPS-induced iNOS and COX-2 expression in RAW264.7 cells by blocking NF-kappaB activation pathway.
Insights
Rheosmin, a compound from pine needles, effectively reduces inflammation markers like nitric oxide and prostaglandin E2. It inhibits key inflammatory pathways, suggesting potential therapeutic benefits for chronic inflammatory diseases.
Area of Science:
- Natural Product Chemistry
- Immunology
- Molecular Biology
Background:
- Inflammation is a critical defense mechanism but aberrant inflammation contributes to chronic diseases like cancer.
- Raspberry ketone is a known phenolic compound used in various industries.
- Understanding natural compounds' anti-inflammatory properties is crucial for developing new therapeutic strategies.
Purpose of the Study:
- To investigate the anti-inflammatory effects of rheosmin, a phenolic compound from pine needles.
- To determine rheosmin's impact on inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expression.
- To elucidate the molecular mechanisms underlying rheosmin's anti-inflammatory action in lipopolysaccharide (LPS)-stimulated cells.
Main Methods:
- Utilized RAW264.7 macrophage cell line stimulated with LPS.
- Quantified nitric oxide (NO) and prostaglandin E2 (PGE2) production.
- Assessed iNOS and COX-2 protein expression.
- Investigated the nuclear translocation of NF-kappaB p65 and IkappaB degradation/phosphorylation.
Main Results:
- Rheosmin demonstrated dose-dependent inhibition of NO and PGE2 production.
- Rheosmin significantly blocked LPS-induced iNOS and COX-2 protein expression.
- Rheosmin inhibited the nuclear translocation of NF-kappaB p65 by preventing IkappaB degradation and phosphorylation, indicating NF-kappaB pathway inhibition.
Conclusions:
- Rheosmin exhibits potent anti-inflammatory properties in LPS-stimulated RAW264.7 cells.
- The mechanism involves the inhibition of NF-kappaB activation pathway.
- Rheosmin's ability to suppress iNOS and COX-2 expression suggests its potential as a therapeutic agent for inflammatory conditions.